ACCELERON PHARMA INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
ACCELERON PHARMA INC. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $218.48 million as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2021-11-04
- 2021-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $218.48M.
- 2021-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $154.47M.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $169.84M.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $153.85M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2021-09-30 | $218.48M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $154.47M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $169.84M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $153.85M 10-K · filed 2021-02-25 |
| 2020-09-30 | $138.78M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $110.55M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $128.04M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $46.26M 10-K · filed 2020-02-27 |
| 2019-09-30 | $16.06M 10-Q · filed 2019-11-06 |
| 2018-12-31 | $23.56M 10-K · filed 2019-02-27 |
| 2017-12-31 | $33.21M 10-K · filed 2018-02-27 |
| 2016-12-31 | $18.42B 10-K · filed 2017-03-01 |
| 2015-12-31 | $75.85B 10-K · filed 2016-02-25 |
| 2015-06-30 | $48.49M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $65.53M 10-Q · filed 2015-05-07 |